SPRAVATO® is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression (TRD). Used alongside an oral antidepressant, this potent supplementary treatment has been shown to quickly and effectively treat major depressive disorders (MDD) including acute suicidal ideation or behavior.
Unlike common antidepressants, which treat depression by increasing levels of neurotransmitters in areas of the brain that affect mood, and traditional Ketamine treatment, which requires an intravenous drip, SPRAVATO® uses a concentrated nasal spray to target the NMDA receptor, and is believed to work differently than currently available prescription antidepressants. The result is fast, effective relief from severe symptoms of major depressive disorder (MDD).
SPRAVATO® is specifically intended for adult individuals who are grappling with severe symptoms associated with major depressive disorders, including suicidal thoughts and behaviors. Additionally, it is intended for those experiencing treatment-resistant depression, a condition that can only be diagnosed and evaluated by a qualified medical professional. If you have undergone two or more preliminary depression treatments, such as talk therapy and prescription medications, or more advanced therapies like TMS or standard Ketamine therapy, without any sustained relief or positive outcomes, then SPRAVATO® could potentially be the ideal solution for you.
The first step towards receiving SPRAVATO® treatment involves undergoing a comprehensive psychiatric evaluation, which is fully covered by insurance. This assessment will help determine if SPRAVATO® is a suitable treatment option for you, especially if you have been diagnosed with treatment-resistant depression and have previously attempted two or more unsuccessful treatments. Once it is established that SPRAVATO® is the best course of action, our certified technicians will provide a thorough explanation of the treatment process and important safety considerations to ensure you are fully informed about what to expect.
During each treatment session, our qualified clinicians will supervise you as you administer the SPRAVATO® nasal spray, demonstrating the correct technique. Following administration, you will be asked to rest comfortably while our staff monitors you closely for any potential side effects. After a two-hour observation period, our technicians will conclude the session, and you will be free to leave.
If you have treatment-resistant depression and want symptom relief, turn to West Coast Ketamine Center in San Diego, CA, for exceptional care. Call the office to learn more about this treatment, or request an appointment online today.